Scoliosis Idiopathic
Conditions
Keywords
anterior vertebral body tethering
Brief summary
Anterior vertebral body tethering (AVBT) is a novel, minimally invasive, growth modulation technique that was recently approved by the FDA under a Humanitarian Device Exemption (HDE). The goal of AVBT is to control curve progression by applying compression on the convex side of the spine deformity. While there has been great initial enthusiasm about the technique as an alternate treatment option to spinal fusion for skeletally immature children with scoliosis, there is a need to better understand the long-term outcomes. The purpose of this study is to report the long-term clinical outcomes of skeletally immature patients treated with AVBT, specifically: 1. The effect on three-dimensional spine growth as compared to normal controls 2. Maintenance of major Cobb angle less than or equal to 50 degrees at skeletal maturity 3. Complications associated with both the procedure and the device
Interventions
Subject will receive anterior vertebral body tethering surgery.
Sponsors
Pediatric Spine Foundation
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No
Inclusion criteria
Skeletally immature patients that receive AVBT surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis. Specifically: * Diagnosis of idiopathic scoliosis * Planned recipient of AVBT surgical treatment * Skeletally immature * Major Cobb angle ≥30° and ≤65° * Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging * Failed or intolerant to bracing
Exclusion criteria
* Presence of any systemic infection, local infection, or skin compromise at the anticipated surgical site * Prior spinal surgery at the level(s) to be treated * Evidence of documented poor bone quality * Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions as determined by the treating physician * Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent * Unwillingness to sign Informed Consent Form and participate in study procedures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The effect on three-dimensional spine growth as compared to normal controls | 5 years | The three-dimensional spine growth of the subjects will be measured at each study timepoint and compared to known normal controls. |
| Maintenance of major Cobb angle less than or equal to 50 degrees at skeletal maturity | 5 years | Subjects who maintain a major Cobb angle less than or equal to 50 degrees at skeletal maturity will be considered a success. |
| Complications associated with both the procedure and the device | 5 years | Subjects will be monitored for complications associated with both the procedure and the device. |
Countries
Canada, United States
Contacts
Primary ContactTyler Farber
Backup ContactTricia St. Hilaire
Outcome results
None listed